ASX medtechs poised to transform healthcare with 2024 catalysts – Part 1.


Optiscan Featured in the Australian Business Review

Optiscan is proud to be featured in the latest Australian Business Review article, spotlighting our forthcoming technological breakthroughs set for 2024. As outlined in the feature, we are on track to launch an innovative breast surgical device this year, aimed at advancing clinical studies and enhancing surgical precision. Additionally, the completion of our state-of-the-art telepathology application is imminent, set to revolutionize the way surgeons and pathologists collaborate towards more accurate diagnoses and effective treatments.

These developments highlight our commitment to leading the charge in optical biopsy technologies, providing real-time, microscopic imaging that reduces the need for traditional biopsies. Our efforts continue to focus on improving patient care through innovative medical technologies, making significant strides in the diagnosis and treatment of cancer and other diseases.

For more details on our upcoming launches and their impact, read our feature in the Australian Business Review here and here.

Select Category